Verified earnings results
Sutro Biopharma Q2 2026 Earnings Results
Sutro Biopharma Q2 2026 reported revenue, operating income and net income.
Direct answer
Sutro Biopharma reported Q2 2026 results on August 12, 2026.
Revenue was 9,839,000. EPS missed the estimate by 4.12%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Sutro Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- August 12, 2026
- Reported timing
- Before the US market opens
- EPS estimate
- -2.2378
- Reported EPS
- -2.33
- Revenue
- 9,839,000
- EPS surprise
- EPS missed the estimate by 4.12%.
Explore related company data
Read the frequently asked questions.
When did Sutro Biopharma report Q2 2026 earnings?
Sutro Biopharma reported on August 12, 2026. The reported timing was before the us market opens.
What is the available EPS estimate for Sutro Biopharma?
The verified record provides an EPS estimate of -2.2378.
Has Sutro Biopharma reported the Q2 2026 result?
Revenue was 9,839,000. EPS missed the estimate by 4.12%.
Which source supports this Sutro Biopharma earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.